Phentermine / Topiramate Extended Release Oral Capsule [Qsymia] for craniopharyngioma

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 8 Mar 2024: Trial registered, NCT06299891
  2. 1 Mar 2025: Trial started, NCT06299891

The trials

NCT06299891: Efficacy and Safety of Phentermine/Topiramate in Youth With Hypothalamic Obesity

State
Under way
Phase
Phase 2
People
24 planned
Started
1 Mar 2025
Primary completion
31 Oct 2026
Arms
Drug Intervention
Results
None posted
  1. 8 Mar 2024: Trial registered
  2. 1 Mar 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.